Origin
is a New Jersey-based clinical-stage biotechnology firm that researches and develops novel therapeutics for the treatment of infections and inflammation... Read moreOrigin
is a New Jersey-based clinical-stage biotechnology firm that researches and develops novel therapeutics for the treatment of infections and inflammation... Read more
Chairman & CEO
Michael Preston
News
Jun 11, 2024
Benzinga
Origin: Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection
May 30, 2023
SEC
Origin: Origin Life Sciences has Received $659.6K in Equity Funding
Origin Competitors
1
2
3
4
5
6
7
8